APGE
Price
$38.54
Change
+$0.41 (+1.08%)
Updated
Sep 24, 11:41 AM (EDT)
Capitalization
2.27B
55 days until earnings call
CGON
Price
$37.46
Change
+$0.76 (+2.07%)
Updated
Sep 24, 11:50 AM (EDT)
Capitalization
2.8B
55 days until earnings call
Interact to see
Advertisement

APGE vs CGON

Header iconAPGE vs CGON Comparison
Open Charts APGE vs CGONBanner chart's image
Apogee Therapeutics
Price$38.54
Change+$0.41 (+1.08%)
Volume$100
Capitalization2.27B
CG Oncology
Price$37.46
Change+$0.76 (+2.07%)
Volume$310
Capitalization2.8B
APGE vs CGON Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. CGON commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and CGON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (APGE: $38.13 vs. CGON: $36.70)
Brand notoriety: APGE and CGON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 63% vs. CGON: 61%
Market capitalization -- APGE: $2.27B vs. CGON: $2.8B
APGE [@Biotechnology] is valued at $2.27B. CGON’s [@Biotechnology] market capitalization is $2.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileCGON’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • CGON’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and CGON are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while CGON’s TA Score has 6 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 3 bearish.
  • CGON’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CGON is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +3.50% price change this week, while CGON (@Biotechnology) price change was +2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +53.89%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

CGON is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.8B) has a higher market cap than APGE($2.27B). CGON YTD gains are higher at: 27.964 vs. APGE (-15.828). CGON has higher annual earnings (EBITDA): -157.09M vs. APGE (-270.1M). CGON has more cash in the bank: 661M vs. APGE (505M). CGON has less debt than APGE: CGON (994K) vs APGE (10.8M). CGON has higher revenues than APGE: CGON (551K) vs APGE (0).
APGECGONAPGE / CGON
Capitalization2.27B2.8B81%
EBITDA-270.1M-157.09M172%
Gain YTD-15.82827.964-57%
P/E RatioN/AN/A-
Revenue0551K-
Total Cash505M661M76%
Total Debt10.8M994K1,087%
TECHNICAL ANALYSIS
Technical Analysis
APGECGON
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 7 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
75%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSAGX51.71N/A
N/A
Fidelity Select Gold
FNCMX290.25N/A
N/A
Fidelity Nasdaq Composite Index
AUUCX21.60-0.11
-0.51%
AB Select US Equity C
BIRIX23.57-0.15
-0.63%
BlackRock Sustainable Adg Lg Cp Cr Instl
RSMOX24.60-0.25
-1.01%
Victory RS Mid Cap Growth A

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+0.45%
SYRE - APGE
55%
Loosely correlated
+4.77%
CRNX - APGE
52%
Loosely correlated
+6.35%
DYN - APGE
49%
Loosely correlated
-1.86%
NUVL - APGE
49%
Loosely correlated
+2.76%
CGON - APGE
49%
Loosely correlated
-0.92%
More

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-0.92%
SYRE - CGON
59%
Loosely correlated
+4.77%
IDYA - CGON
57%
Loosely correlated
+0.04%
XNCR - CGON
56%
Loosely correlated
-0.67%
KYMR - CGON
56%
Loosely correlated
-0.27%
CRNX - CGON
55%
Loosely correlated
+6.35%
More